180 related articles for article (PubMed ID: 37051530)
1. Preclinical modeling of lower-grade gliomas.
Tang LW; Mallela AN; Deng H; Richardson TE; Hervey-Jumper SL; McBrayer SK; Abdullah KG
Front Oncol; 2023; 13():1139383. PubMed ID: 37051530
[TBL] [Abstract][Full Text] [Related]
2. Establishment of patient-derived organoid models of lower-grade glioma.
Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Models of Low-Grade Gliomas.
Dasgupta P; Balasubramanyian V; de Groot JF; Majd NK
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765553
[TBL] [Abstract][Full Text] [Related]
4. Pediatric low-grade glioma models: advances and ongoing challenges.
Yvone GM; Breunig JJ
Front Oncol; 2023; 13():1346949. PubMed ID: 38318325
[TBL] [Abstract][Full Text] [Related]
5. A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening.
Zhang L; Liu F; Weygant N; Zhang J; Hu P; Qin Z; Yang J; Cheng Q; Fan F; Zeng Y; Tang Y; Li Y; Tang A; He F; Peng J; Liao W; Hu Z; Li M; Liu Z
Cancer Lett; 2021 Mar; 500():87-97. PubMed ID: 33309780
[TBL] [Abstract][Full Text] [Related]
6. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
[TBL] [Abstract][Full Text] [Related]
8. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
9. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
10. Modeling nervous system tumors with human stem cells and organoids.
Duan J; Wang Y
Cell Regen; 2023 Mar; 12(1):4. PubMed ID: 36854987
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
12. Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.
Ye L; Xu Y; Hu P; Wang L; Yang J; Yuan F; Wang Y; Zhang C; Tian D; Chen Q
Front Mol Neurosci; 2021; 14():720899. PubMed ID: 34776862
[No Abstract] [Full Text] [Related]
13. Glioma: experimental models and reality.
Lenting K; Verhaak R; Ter Laan M; Wesseling P; Leenders W
Acta Neuropathol; 2017 Feb; 133(2):263-282. PubMed ID: 28074274
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
[TBL] [Abstract][Full Text] [Related]
15. Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading.
Pei L; Jones KA; Shboul ZA; Chen JY; Iftekharuddin KM
Front Oncol; 2021; 11():668694. PubMed ID: 34277415
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
PeerJ; 2020; 8():e8312. PubMed ID: 31921517
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
Wu S; Miao K; Wang L; Ma Y; Wu X
Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510
[TBL] [Abstract][Full Text] [Related]
18. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
McDuff SGR; Dietrich J; Atkins KM; Oh KS; Loeffler JS; Shih HA
Cancer Med; 2020 Jan; 9(1):3-11. PubMed ID: 31701682
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
20. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
Chen P; Han H; Wang X; Wang B; Wang Z
Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]